Effective treatment of atopic dermatitis by cutaneous application of non-pathogenic bacteria Vitreoscilla filiformis ointment 5%: Results from a randomised, double-blind, vehicle-controlled study

被引：0
|
作者：
Gueniche, A. [1 ]
Piche, E. [2 ]
Voltz, T. [2 ]
Breton, L. [1 ]
Biedermann, T. [2 ]
机构：
[1] LOreal, Clichy, France
[2] Univ Tubingen, Dept Dermatol, Tubingen, Germany
来源：
ALLERGY | 2008年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
890
引用
收藏
页码：329 / 329
页数：1
相关论文
共 50 条
  • [1] Effective treatment of atopic dermatitis by cutaneous application of non-pathogenic bacteria Vitreoscilla filiformis ointment 5%:: Results from a randomized, double-blind, vehicle-controlled study
    Gueniche, A.
    Knaudt, B.
    Piche, E.
    Volz, T.
    Roecken, M.
    Biedermann, T.
    Bastien, P.
    Breton, L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S18 - S18
  • [2] Prednicarbate 0.25% ointment in the treatment of atopic dermatitis: A vehicle-controlled double-blind study
    Lawlor, F
    Black, AK
    Greaves, M
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 1995, 6 (04) : 233 - 235
  • [3] Antimicrobial activity of Vitreoscilla filiformis lysate: Results from a randomized, double-blind, vehicle-controlled study and in vitro study
    Gueniche, A.
    Bastien, P.
    Mahe, Y.
    Billoni, N.
    Knaudt, B.
    Piche, E.
    Voltz, T.
    Rocken, M.
    Biedermann, T.
    Breton, L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S18 - S18
  • [4] Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: Results from a randomized, double-blind, vehicle-controlled study
    Schachner, LA
    Lamerson, C
    Sheehan, MP
    Boguniewicz, M
    Mosser, J
    Raimer, S
    Shull, T
    Jaracz, E
    [J]. PEDIATRICS, 2005, 116 (03) : E334 - E342
  • [5] Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial
    Saeki, Hidehisa
    Ito, Kensuke
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (03) : 607 - 614
  • [6] The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study
    Afshar, M.
    Kotol, P.
    Miller, J.
    Gallo, R.
    Hata, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 426 - 428
  • [7] A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclairo®), in the treatment of mild to moderate atopic dermatitis
    Belloni, G
    Pinelli, S
    Veraldi, S
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2005, 15 (01) : 31 - 36
  • [8] Clindamycin/benzoyl peroxide in the treatment of perioral dermatitis: A double-blind, randomized, vehicle-controlled study
    Draelos, Z
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB85 - AB85
  • [9] The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study
    Holst, R. Foelster
    Reitamo, S.
    Yankova, R.
    Worm, M.
    Kadurina, M.
    Thaci, K.
    Bieber, T.
    Tsankov, N.
    Enk, A.
    Luger, T.
    Duffy, M.
    Tansley, R.
    [J]. ALLERGY, 2010, 65 (12) : 1594 - 1599
  • [10] Pimecrolimus cream 1% for the treatment of facial atopic dermatitis: Exploratory analysis of a double-blind, randomized, vehicle-controlled study in pediatric patients
    Korman, Neil
    Kianifard, Farid
    Parneix-Spike, Anne
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB107 - AB107
12345